Department of Neuro-Interventional Surgery, Christiana Care Hospital, Newark, Delaware.
J Neurosurg. 2014 Oct;121(4):995-8. doi: 10.3171/2014.4.JNS132187. Epub 2014 Jun 13.
The authors report a case of an intracranial extravasation during the withdrawal of a Trevo ProVue stent retriever device in a patient being treated for acute ischemic stroke. An 82-year-old woman developed sudden left hemiparesis and aphasia during an urgent cardiac catheterization procedure for a non-ST elevation myocardial infarction. She had a baseline National Institutes of Health Stroke Scale (NIHSS) score of at least 10 and no improvement with intravenous administration of tissue plasminogen activator (tPA). Cerebral angiography was performed with conscious sedation, confirming an occlusion of the superior division of the right middle cerebral artery (MCA). Using standard technique, a Trevo thrombectomy device was deployed across the clot. Post-thrombectomy control angiography demonstrated complete revascularization of the right MCA. The device was then gently withdrawn without difficulty. Immediately afterward the patient's blood pressure showed a sudden and significant elevation. Immediate posttreatment angiography demonstrated active extravasation from the posterior wall of the communicating segment of the right internal carotid artery. Rapid cessation of bleeding was achieved with intravenous administration of protamine and induced hypotension. Immediate neurological assessment was performed, which showed motor improvement. An immediate postintervention CT scan confirmed a moderate-sized subarachnoid hemorrhage and contrast in the prepontine cistern. The patient was discharged home on postoperative Day 3 with an NIHSS score of zero. At 6-month follow-up in the neurointerventional clinic, her NIHSS and modified Rankin Scale scores were both zero. Endovascular stent retriever devices are increasingly being used as first-line thrombectomy devices in acute embolic strokes. A unique and previously undescribed complication is vessel perforation during withdrawal of a stent retriever. Conservative treatment options and reversal of anticoagulation should be the first line of treatment for such complications. In the authors' case, performing the procedure without anesthesia was helpful in assessing the patient's neurological status.
作者报告了一例在使用 Trevo ProVue 支架取出装置取栓过程中发生颅内外渗的病例,该患者正在接受急性缺血性脑卒中的治疗。一位 82 岁女性在行非 ST 段抬高型心肌梗死紧急经皮冠状动脉介入治疗时突发左侧偏瘫和失语。她的基线国立卫生研究院卒中量表(NIHSS)评分为至少 10 分,静脉注射组织型纤溶酶原激活剂(tPA)后无改善。在清醒镇静下进行了脑血管造影,证实右侧大脑中动脉(MCA)上部分支闭塞。采用标准技术,将 Trevo 取栓装置部署在血栓部位。取栓后控制血管造影显示右侧 MCA 完全再通。然后轻松地将装置缓慢撤出。就在此时,患者的血压突然显著升高。即刻治疗后血管造影显示右侧颈内动脉交通段后壁有明显的外渗。静脉注射鱼精蛋白和诱导低血压后迅速停止出血。立即进行神经功能评估,发现运动功能改善。即刻介入后 CT 扫描证实中等量蛛网膜下腔出血和桥前池造影剂外渗。术后第 3 天,患者出院,NIHSS 评分为 0 分。在神经介入门诊 6 个月随访时,她的 NIHSS 和改良 Rankin 量表评分均为 0 分。血管内支架取栓装置越来越多地被用作急性栓塞性脑卒中的一线取栓装置。一种独特且以前未描述过的并发症是在取出支架取栓装置时发生血管穿孔。对于此类并发症,应首先选择保守治疗和逆转抗凝。在作者的病例中,在不进行麻醉的情况下进行手术有助于评估患者的神经状态。